Kewaunee Scientific Corp (KEQU)
NASDAQConsumer DiscretionaryFurnishings, Fixtures & AppliancesSnapshot 2026-09-04
$36.99+0.52%
Close 2026-09-04 · 1-day change
NASDAQConsumer DiscretionaryFurnishings, Fixtures & AppliancesSnapshot 2026-09-04
QuarterlyIQ Insights · KEQU
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Continue executing the growth strategy with disciplined capital allocation to support organic and inorganic growth.
Newly stated in 2026-Q2. Management emphasized continuing execution of the growth strategy with disciplined capital allocation. Revenue grew from $240.5M in FY2025 to $282.0M in FY2026, reflecting a 17.3% increase. This growth trajectory aligns with management's stated focus on growth execution.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Consumer Discretionary names rated neutral grew net income 45% of the time over the next year (vs 59% for the rest of the cohort, n=6943).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“As we enter fiscal 2027, Kewaunee is well positioned to continue executing its growth strategy.”
Continue integration of the Nu Aire acquisition to expand and strengthen the laboratory products portfolio.
Newly stated in 2026-Q2. Management reported significant progress integrating Nu Aire, enhancing the product portfolio. While no specific financial metrics were provided for integration impact, the company highlighted this as a key strategic priority supporting future growth.
“Significant progress integrating Nu Aire, positioning the business for improved performance.”
Reduce long-term debt and improve debt-to-equity ratio by repaying acquisition-related liabilities.
Newly stated in 2026-Q2. Management focused on strengthening the balance sheet by reducing acquisition-related debt. Long-term debt decreased from $60.7M in FY2025 to $40.9M in FY2026, and the debt-to-equity ratio improved from 0.99-to-1 to 0.61-to-1, demonstrating clear progress on this priority.
“Reduced long-term debt by ~$20M and completed repayment of Seller Notes from Nu Aire acquisition.”
Address operational challenges including project delivery volatility and input cost pressures through disciplined cost management.
Newly stated in 2026-Q2. Management emphasized disciplined cost controls to manage operational challenges. Gross profit increased from $70.4M in FY2025 to $80.4M in FY2026, indicating operational improvements consistent with management's stated focus.
“Continued productivity improvements and disciplined cost controls mitigated headwinds.”
Over the trailing year it converted 1.47x of net income into operating cash flow. Historically, Consumer Discretionary names rated neutral grew net income 49% of the time over the next year (vs 49% for the rest of the cohort, n=4864).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, Fed net liquidity, long-term interest rates (low R² over the window).
7 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Consumer Discretionary names rated stable grew net income 47% of the time over the next year (vs 53% for the rest of the cohort, n=1906).
Not investment advice. As of 2026-09-04.